Summary
Using the technique of short interval sequential tetracycline labeling, it was documented that the apposition of mineralized bone matrix in adult male Sprague-Dawley rats was inhibited by hydrocortisone. The inhibition occurred as early as six days after the onset of the treatment and was dose dependent over a dose range of 0.62 to 20 mg per kg body weight per day. Vitamin D2 supplements by injection protected bone from this hydrocortisone action. 64 I. U. of vitamin D2 injected daily was able to prevent the inhibition of bone apposition by 20 mg per kg body weight per day of hydrocortisone. The results imply that vitamin D or its metabolites may compete with hydrocortisone in some cellular mechanisms and support the usefulness of vitamin D supplements in the treatment and the prevention of steroid-induced osteoporosis.
Similar content being viewed by others
References
Deding, A., Tougarard, L., Jensen, M.K., et al.: Bone changes during prednisone treatment, Acta Med. Scand.202:253–255, 1977
Chesney, R.W., Mazess, R.B., Rose, P., et al.: Effect of prednisone on growth and bone mineral content in childhood glomerular diseases, Am. J. Dis. Child.132:768–772, 1978
Klein, R.G., Arnaud, S.B., Gallagher, J.C., et al.: Intestinal calcium absorption in exogenous hypercortisonism. Role of 25 hydroxyvitamin D and corticosteroid dose, J. Clin. Invest.60:253–259, 1977
Younoszai, M.K., Gishan, F.K.: In vivo intestinal calcium absorption in infant rats: influence of methylprednisolone and vitamin D, Proc. Soc. Exp. Biol. Med.158:174–178, 1978
Fox, J., Case, A.D., Blados, J.: Effect of low calcium and low phosphorous diet on the duodenal absorption of calcium in betamethasone treated chicks, J. Endocrinol.78:255–260, 1978
Avioli, L.V., Brige, S.J., Lee, S.W.: Effects of prednisone on vitamin D metabolism in man, J. Clin. Endocrinol. Metab.28:1341–1364, 1968
Carre, M., Ayegbebe, O., Miravel, L., et al.: The effect of prednisone upon the metabolism and action of 25 hydroxy and 1α, 25 dihydroxyvitamin D3, Proc. Natl. Acad. Sci. U.S.A.71:2996–3000, 1974
Haussler, M.R., McCain, T.A.: Basic and clinical concepts related to vitamin D metabolism and action, N. Engl. J. Med.297:974–983, 1041–1050, 1977
Colemen, R., Silver, M.: Ultrastructure of parathyroid glands in triamcinolone treated mice, J. Anat.126:181–192, 1978
Weisebrode, S.E., Capen, C.C.: Ultrastructural evaluation of interaction of glucocorticoid and vitamin D on bone cells in thyroparathyroidectomized rats, Am. J. Pathol.84:457–468, 1976
Fucik, R.F., Kukreja, S.C., Hargis, G.K., et al.: Effects of glucocorticoids on the function of the parathyroid glands in man, J. Clin. Endocrinol. Metab.40:152–155, 1975
Hahn, T.J., Hahn, B.H.: Osteopenia in patients with rheumatic disease. Principles of diagnosis and therapy, Semin. Arth. Rheum.6:165–188, 1976
Chen, T.L., Feldman, D.: Glucocorticoid potentiation of the adenosine 3′5′ monophosphate response to parathyroid hormone in cultured bone cells, Endocrinology102:589–596, 1978
Ng, B., Hekkelman, J.W., Heersche, J.N.M.: The effect of cortisol on the adenosine 3′5′ monophosphate response to parathyroid hormone of bone in vitro, Endocrinology104:1130–1135, 1979
Choe, J., Stern, P., Feldman, D.: Receptor mediated glucocorticoid inhibition of protein synthesis in isolated bone cells, J. Steroid Biochem.9:265–271, 1978
Tam, C.S., Reed, R., Cruickshank, B.: Bone growth kinetics. I: Modifications of the tetracycline labelling technique, J. Pathol.113:27–39, 1978
Tam, C.S., Harrison, J.E., Reed, R., et al.: Bone apposition rate as an index of bone metabolism, Metabolism27:143–150, 1978
Tam, C.S., Anderson, W.: Tetracycline labelling of bone in vivo, Calcif. Tissue Int.30:121–125, 1980
Park, H.Z., Jee, K.W., Burggraaf, R., et al.: Dicotomy of effects of cortisol upon metaphyseal bone, J. Dent. Res.49:77, 1970
Jee, W.S.S., Roberts, W.E., Park, H.Z., et al.: Interrelated effects of glucocorticoid and parathyroid hormone upon bone remodeling. In R.V. Talmage, P.L. Munson (eds.): Calcium, Parathyroid Hormone and the Calcitonins, pp. 430–439. Excerpta Medica, Amsterdam, 1972
Chesney, R.W., Mazess, R.B., Hamstra, H.J., et al.: Reduction of serum-1-25-dihydroxyvitamin-D3 in children receiving glucocorticoids, LancetII:1123–1125, 1978
O'Regan, S., Chesney, R.W., Hamstra, E., et al.: Reduced serum 1,25 (OH)2 vitamin D3 levels in prednisone-treated adolescents with systemic lupus erythematosus, Acta Paediatr. Scand.68:109–111, 1979
Lund, B., Sørensen, O.H., Lund, B.: Clinical application of the 1,25 (OH2)D assay In A.W. Norman (ed.): Vitamin D, Basic Research and Its Clinical Application, pp. 991–997. Walter de Greuter, Berlin, 1979
Wong, G.L.: Basal activities and hormone responsiveness of osteoclast-like and osteoblast-bone cells are regulated by glucocorticoids, J. Biol. Chem.254:6337–6342, 1979
Tam, C.S., Wilson, D.R., Harrison, J.E.: Effect of parathyroid extract on bone apposition and the interaction between parathyroid hormone and vitamin D, Mineral Electrolyte Metab.3:74–80, 1980
Tam, C.S., Murray, T.M., Heersche, J.N.M.: Stimulation of bone formation by parathormone (PTH) in vivo, Calcif Tissue Int.28(2):151, 1979
Welken, W.R., Henry, H.R., Norman, A.W.: Studies in the mode of action of calciferol in chick parathyroid gland, Arch. Biochem. Biophys.183:168–175, 1977
Stumpf, W.E., Sar, M., Reid, F.A., et al.: Target cells for 1,25 dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary and parathyroid, Science206:1180–90, 1979
Tata, J.R., Smith, D.F.: Vitellogenesis: a versatile model for hormonal regulation of gene expression, Recent Prog. Horm. Res.35:47–95, 1979
Manolagas, S.C., Anderson, D.C.: Detection of high affinity glucocorticoid binding protein in rat bone, J. Endocrinol.76:379–380, 1978
Fox, J., Care, A.D., Marshall, D.H.: Reversal of betamethasone-induced inhibition of intestinal absorption by 1α hydroxycholecalciferol, J. Endocrinol.78:187–194, 1976
Lindgren, U., Lindholm, S., Sarby, B.: Short term effects of 1 alpha-hydroxyvitamin D3 in patients on corticosteroid treatment and patients with senile osteoporosis, Acta Med. Scand.204:89–92, 1978
Condon, J.R., Nassim, J.R., Dent, C.E., et al.: Possible prevention and treatment of steroid induced osteoporosis, Postgrad. Med. J.54:249–252, 1978
Hahn, T.J., Halstead, L.R., Teitelbaum, S.L.: Altered mineral metabolism in glucocorticoid-induced administration, J. Clin. Invest.64:655–665, 1979
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tam, C.S., Wilson, D.R., Hitchman, A.J. et al. Protective effect on vitamin D2 on bone apposition from the inhibitory action of hydrocortisone in rats. Calcif Tissue Int 33, 167–172 (1981). https://doi.org/10.1007/BF02409430
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02409430